Theranica
Manufacturing · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4 Ha-omanut St, Netanya, Central Distric...Phone Number
+972 723909761Website
www.theranica.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Theranica
Theranica is a prescribed digital therapeutics company dedicated to creating effective, safe, affordable, low-side-effect therapies for idiopathic pain conditions. The company's award-winning flagship wearable, Nerivio®, is the first FDA-cleared prescribed migraine REN Wearable for acute and/or preventive treatment of migraine. Theranica is expanding its proprietary technology to develop solutions for additional idiopathic pain conditions.Explore more
Theranica Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Theranica your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Theranica recently announced quarterly report
Theranica, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Theranica has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Theranica has new funding data
Product Launch: Get notified when Theranica launches new products
Website visits: Recent activity has been detected on your website
Check out if Theranica is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Theranica
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Theranica had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Theranica
Find more new buyers
Company Profile Activity
Activity Insights
Theranica is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Theranica is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Theranica.
Theranica financials insights
Gather financial insights about Theranica, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Series A
$6M
2019
Series B
$35M
2022
Series C
$45M
Theranica Tech Stack
A closer look at the technologies used by Theranica
Most Recent Scoops
Left Company
Executive Move
Executive Moves, Left Company
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Hiring Plans
Theranica has more open roles in Sales than it has had at any time in the past 12 months with an increased focus that include Medical Sales, and experience with Regional Sales, and Sales Performance Management.
Hiring Plans
Hiring Plans
Hiring Plans
Theranica News & Media
Theranica Announces U.S. Coverage for Nerivio® Reaching ~130 Million Lives, Attaining Payer Scale Comparable to Leading Migraine Drugs
Major Nationwide Coverage Expansion by the Blue Cross Blue Shield Association and Multiple BCBS Independent Licensees (Member Plans) Position the Remote Electrical Neuromodulation Wearable Device as a Widely Reimbursed, Mainstream Migraine Treatment Option BRIDGEWATER, N.J. and NETANYA,...Theranica Brings First-in-Class, Drug-Free Migraine Care to the Forefront at CNS 2025 with Product Theater and New Real-World Evidence
With a dedicated product theater and new real-world evidence posters, Theranica will spotlight how the Nerivio® REN wearable is reshaping pediatric migraine care—offering families a proven, drug-free alternative to migraine treatment BRIDGEWATER, N.J. and NETANYA, Israel, Oct. 8, 2025...Pier 88 Health and Theranica Announce China NMPA Approval of the Nerivio® REN wearable for Acute Treatment of Migraine
First and Only REN-Based Migraine Treatment Approved in China BEIJING and NETANYA, Israel, Sept. 30, 2025 /PRNewswire/ -- Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global medical innovations to Greater China, and Theranica, a prescribed digital therapeutics company, today announced that the Nerivio® REN wearable, a novel treatment of migraine, has received regulatory approval from China's National Medical Products AdministraTheranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment
Theranica is presenting three real-world evidence studies at the American Headache Society (AHS) 67th Annual Scientific Congress.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Theranica
Sign Up For FreeTo access detailed company insights
Theranica is a prescribed digital therapeutics company dedicated to creating effective, safe, affordable, low-side-effect therapies for idiopathic pain conditions. The company's award-winning flagship wearable, Nerivio®, is the first FDA-cleared prescribed migraine REN Wearable for acute and/or preventive treatment of migraine. Theranica is expandi... Read More
